1887

Abstract

In 2006, a new retrovirus was isolated from prostate cancer patient tissue. Named xenotropic murine leukemia virus-related virus (XMRV), this was potentially the third class of retrovirus to be pathogenic in humans. XMRV made a more dramatic impact on the wider scientific community, and indeed the media, in 2009 when it was reported to be present in a remarkably high proportion of patients with chronic fatigue syndrome as well as a significant, albeit smaller, proportion of healthy controls. The apparent strong link to disease and the fear of a previously unknown retrovirus circulating in the general population lead to a surge in XMRV research. Subsequent studies failed to find an association of XMRV with disease and, in most cases, failed to find the virus in human samples. In 2011, the case against XMRV and human disease strengthened, ending with several decisive publications revealing the origin of the virus and demonstrating contamination of samples. In this review, we outline the passage of research on XMRV and its potential association with disease from its isolation to the present day, where we find ourselves at the end of a turbulent story.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.041038-0
2012-05-01
2020-08-08
Loading full text...

Full text loading...

/deliver/fulltext/jgv/93/5/915.html?itemId=/content/journal/jgv/10.1099/vir.0.041038-0&mimeType=html&fmt=ahah

References

  1. Alberts B.. 2011a; Editorial expression of concern. Science333:35 [CrossRef][PubMed]
    [Google Scholar]
  2. Alberts B.. 2011b; Retraction. Science334:1636 [CrossRef][PubMed]
    [Google Scholar]
  3. Arnold R. S., Makarova N. V., Osunkoya A. O., Suppiah S., Scott T. A., Johnson N. A., Bhosle S. M., Liotta D., Hunter E.. other authors 2010; XMRV infection in patients with prostate cancer: novel serologic assay and correlation with PCR and FISH. Urology75:755–761 [CrossRef][PubMed]
    [Google Scholar]
  4. Balada E., Castro-Marrero J., Felip L., Vilardell-Tarrés M., Ordi-Ros J.. 2011; Xenotropic murine leukemia virus-related virus (XMRV) in patients with systemic lupus erythematosus. J Clin Immunol31:584–587 [CrossRef][PubMed]
    [Google Scholar]
  5. Bansal A. S., Bradley A. S., Bishop K. N., Kiani-Alikhan S., Ford B.. 2012; Chronic fatigue syndrome, the immune system and viral infection. Brain Behav Immun26:24–31 [CrossRef][PubMed]
    [Google Scholar]
  6. Barnes E., Flanagan P., Brown A., Robinson N., Brown H., McClure M., Oxenius A., Collier J., Weber J.. other authors 2010; Failure to detect xenotropic murine leukemia virus-related virus in blood of individuals at high risk of blood-borne viral infections. J Infect Dis202:1482–1485 [CrossRef][PubMed]
    [Google Scholar]
  7. Battini J. L., Rasko J. E., Miller A. D.. 1999; A human cell-surface receptor for xenotropic and polytropic murine leukemia viruses: possible role in G protein-coupled signal transduction. Proc Natl Acad Sci U S A96:1385–1390 [CrossRef][PubMed]
    [Google Scholar]
  8. Bogerd H. P., Zhang F., Bieniasz P. D., Cullen B. R.. 2011; Human APOBEC3 proteins can inhibit xenotropic murine leukemia virus-related virus infectivity. Virology410:234–239 [CrossRef][PubMed]
    [Google Scholar]
  9. Casey G., Neville P. J., Plummer S. J., Xiang Y., Krumroy L. M., Klein E. A., Catalona W. J., Nupponen N., Carpten J. D.. other authors 2002; RNASEL Arg462Gln variant is implicated in up to 13 % of prostate cancer cases. Nat Genet32:581–583 [CrossRef][PubMed]
    [Google Scholar]
  10. Cohen J., Enserink M.. 2011; Virology. False positive. Science333:1694–1701 [CrossRef][PubMed]
    [Google Scholar]
  11. Cornelissen M., Zorgdrager F., Blom P., Jurriaans S., Repping S., van Leeuwen E., Bakker M., Berkhout B., van der Kuyl A. C.. 2010; Lack of detection of XMRV in seminal plasma from HIV-1 infected men in The Netherlands. PLoS One5:e12040 [CrossRef][PubMed]
    [Google Scholar]
  12. Danielson B. P., Ayala G. E., Kimata J. T.. 2010; Detection of xenotropic murine leukemia virus-related virus in normal and tumor tissue of patients from the southern United States with prostate cancer is dependent on specific polymerase chain reaction conditions. J Infect Dis202:1470–1477 [CrossRef][PubMed]
    [Google Scholar]
  13. DeFreitas E., Hilliard B., Cheney P. R., Bell D. S., Kiggundu E., Sankey D., Wroblewska Z., Palladino M., Woodward J. P., Koprowski H.. 1991; Retroviral sequences related to human T-lymphotropic virus type II in patients with chronic fatigue immune dysfunction syndrome. Proc Natl Acad Sci U S A88:2922–2926 [CrossRef][PubMed]
    [Google Scholar]
  14. Dodd R. Y., Hackett J. Jr, Linnen J. M., Dorsey K., Wu Y., Zou S., Qiu X., Swanson P., Schochetman G.. other authors 2012; Xenotropic murine leukemia virus-related virus does not pose a risk to blood recipient safety. Transfusion52:298–306[PubMed][CrossRef]
    [Google Scholar]
  15. Dong B., Silverman R. H.. 2010; Androgen stimulates transcription and replication of xenotropic murine leukemia virus-related virus. J Virol84:1648–1651 [CrossRef][PubMed]
    [Google Scholar]
  16. Dong B., Kim S., Hong S., Das Gupta J., Malathi K., Klein E. A., Ganem D., Derisi J. L., Chow S. A., Silverman R. H.. 2007; An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc Natl Acad Sci U S A104:1655–1660 [CrossRef][PubMed]
    [Google Scholar]
  17. Erlwein O., Kaye S., McClure M. O., Weber J., Wills G., Collier D., Wessely S., Cleare A.. 2010; Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome. PLoS One5:e8519 [CrossRef][PubMed]
    [Google Scholar]
  18. Erlwein O., Robinson M. J., Dustan S., Weber J., Kaye S., McClure M. O.. 2011; DNA extraction columns contaminated with murine sequences. PLoS One6:e23484 [CrossRef][PubMed]
    [Google Scholar]
  19. Fischer N., Schulz C., Stieler K., Hohn O., Lange C., Drosten C., Aepfelbacher M.. 2010; Xenotropic murine leukemia virus-related gammaretrovirus in respiratory tract. Emerg Infect Dis16:1000–1002[PubMed][CrossRef]
    [Google Scholar]
  20. Frankel W. N., Stoye J. P., Taylor B. A., Coffin J. M.. 1990; A linkage map of endogenous murine leukemia proviruses. Genetics124:221–236[PubMed]
    [Google Scholar]
  21. Fredericks D. N., Relman D. A.. 1996; Sequence-based identification of microbial pathogens: a reconsideration of Koch’s postulates. Clin Microbiol Rev9:18–33[PubMed]
    [Google Scholar]
  22. Garson J. A., Kellam P., Towers G. J.. 2011; Analysis of XMRV integration sites from human prostate cancer tissues suggests PCR contamination rather than genuine human infection. Retrovirology8:13 [CrossRef][PubMed]
    [Google Scholar]
  23. Gray E. R., Garson J. A., Breuer J., Edwards S., Kellam P., Pillay D., Towers G. J.. 2011; No evidence of XMRV or related retroviruses in a London HIV-1-positive patient cohort. PLoS One6:e18096 [CrossRef][PubMed]
    [Google Scholar]
  24. Groom H. C., Boucherit V. C., Makinson K., Randal E., Baptista S., Hagan S., Gow J. W., Mattes F. M., Breuer J.. other authors 2010a; Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome. Retrovirology7:10 [CrossRef][PubMed]
    [Google Scholar]
  25. Groom H. C., Yap M. W., Galão R. P., Neil S. J., Bishop K. N.. 2010b; Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors. Proc Natl Acad Sci U S A107:5166–5171 [CrossRef][PubMed]
    [Google Scholar]
  26. Hartley J. W., Wolford N. K., Old L. J., Rowe W. P.. 1977; A new class of murine leukemia virus associated with development of spontaneous lymphomas. Proc Natl Acad Sci U S A74:789–792 [CrossRef][PubMed]
    [Google Scholar]
  27. Hassel B. A., Zhou A., Sotomayor C., Maran A., Silverman R. H.. 1993; A dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon. EMBO J12:3297–3304[PubMed]
    [Google Scholar]
  28. Henrich T. J., Li J. Z., Felsenstein D., Kotton C. N., Plenge R. M., Pereyra F., Marty F. M., Lin N. H., Grazioso P.. other authors 2010; Xenotropic murine leukemia virus-related virus prevalence in patients with chronic fatigue syndrome or chronic immunomodulatory conditions. J Infect Dis202:1478–1481 [CrossRef][PubMed]
    [Google Scholar]
  29. Hill A. B.. 1965; The environment and disease: association or causation?. Proc R Soc Med58:295–300[PubMed]
    [Google Scholar]
  30. Hong S., Klein E. A., Das Gupta J., Hanke K., Weight C. J., Nguyen C., Gaughan C., Kim K. A., Bannert N.. other authors 2009; Fibrils of prostatic acid phosphatase fragments boost infections with XMRV (xenotropic murine leukemia virus-related virus), a human retrovirus associated with prostate cancer. J Virol83:6995–7003 [CrossRef][PubMed]
    [Google Scholar]
  31. Hong P., Li J., Li Y.. 2010; Failure to detect Xenotropic murine leukaemia virus-related virus in Chinese patients with chronic fatigue syndrome. Virol J7:224 [CrossRef][PubMed]
    [Google Scholar]
  32. Hué S., Gray E. R., Gall A., Katzourakis A., Tan C. P., Houldcroft C. J., McLaren S., Pillay D., Futreal A.. other authors 2010; Disease-associated XMRV sequences are consistent with laboratory contamination. Retrovirology7:111 [CrossRef][PubMed]
    [Google Scholar]
  33. Inglis T. J.. 2007; Principia aetiologica: taking causality beyond Koch’s postulates. J Med Microbiol56:1419–1422 [CrossRef][PubMed]
    [Google Scholar]
  34. Jeziorski E., Foulongne V., Ludwig C., Louhaem D., Chiocchia G., Segondy M., Rodière M., Sitbon M., Courgnaud V.. 2010; No evidence for XMRV association in pediatric idiopathic diseases in France. Retrovirology7:63 [CrossRef][PubMed]
    [Google Scholar]
  35. Kai K., Furuta T.. 1984; Isolation of paralysis-inducing murine leukemia viruses from Friend virus passaged in rats. J Virol50:970–973[PubMed]
    [Google Scholar]
  36. Kim S., Kim N., Dong B., Boren D., Lee S. A., Das Gupta J., Gaughan C., Klein E. A., Lee C.. other authors 2008; Integration site preference of xenotropic murine leukemia virus-related virus, a new human retrovirus associated with prostate cancer. J Virol82:9964–9977 [CrossRef][PubMed]
    [Google Scholar]
  37. Knox K., Carrigan D., Simmons G., Teque F., Zhou Y., Hackett J. Jr, Qiu X., Luk K. C., Schochetman G.. other authors 2011; No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected. Science333:94–97 [CrossRef][PubMed]
    [Google Scholar]
  38. Kozak C. A.. 2010; The mouse “xenotropic” gammaretroviruses and their XPR1 receptor. Retrovirology7:101 [CrossRef][PubMed]
    [Google Scholar]
  39. Kunstman K. J., Bhattacharya T., Flaherty J., Phair J. P., Wolinsky S. M.. 2010; Absence of xenotropic murine leukemia virus-related virus in blood cells of men at risk for and infected with HIV. AIDS24:1784–1785 [CrossRef][PubMed]
    [Google Scholar]
  40. Levy J. A.. 1999; Xenotropism: the elusive viral receptor finally uncovered. Proc Natl Acad Sci U S A96:802–804 [CrossRef][PubMed]
    [Google Scholar]
  41. Levy J. A., Pincus T.. 1970; Demonstration of biological activity of a murine leukemia virus of New Zealand black mice. Science170:326–327 [CrossRef][PubMed]
    [Google Scholar]
  42. Linial M. L., Fan H., Hahn B., Löwer R., Neil J., Quackenbush S., Rethwilm A., Sonigo P., Stoye J., Tristem M.. 2005; Retroviridae. In Virus Taxonomy: Eighth Report of the International Committee on Taxonomy of Viruses pp.421–440 Edited by Fauquet C. M., Mayo M. A., Maniloff J., Desselberger U., Ball L. A.. San Diego, CA: Elsevier Academic Press;
    [Google Scholar]
  43. Lintas C., Guidi F., Manzi B., Mancini A., Curatolo P., Persico A. M.. 2011; Lack of infection with XMRV or other MLV-related viruses in blood, post-mortem brains and paternal gametes of autistic individuals. PLoS One6:e16609 [CrossRef][PubMed]
    [Google Scholar]
  44. Lloyd A., White P., Wessely S., Sharpe M., Buchwald D.. 2010; Comment on “Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome”. Science328:825 [CrossRef][PubMed]
    [Google Scholar]
  45. Lo S. C., Pripuzova N., Li B., Komaroff A. L., Hung G. C., Wang R., Alter H. J.. 2010; Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors. Proc Natl Acad Sci U S A107:15874–15879 [CrossRef][PubMed]
    [Google Scholar]
  46. Lo S. C., Pripuzova N., Li B., Komaroff A. L., Hung G. C., Wang R., Alter H. J.. 2012; Retraction for Lo et al., Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors. Proc Natl Acad Sci U S A109:346 [CrossRef][PubMed]
    [Google Scholar]
  47. Lombardi V. C., Ruscetti F. W., Das Gupta J., Pfost M. A., Hagen K. S., Peterson D. L., Ruscetti S. K., Bagni R. K., Petrow-Sadowski C.. other authors 2009; Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science326:585–589 [CrossRef][PubMed]
    [Google Scholar]
  48. Luczkowiak J., Sierra O., González-Martín J. J., Herrero-Beaumont G., Delgado R.. 2011; No xenotropic murine leukemia virus-related virus detected in fibromyalgia patients. Emerg Infect Dis17:314–315[PubMed][CrossRef]
    [Google Scholar]
  49. Luczkowiak J., Martínez-Prats L., Sierra O., Fiorante S., Rubio R., Pulido F., Otero J. R., Delgado R.. 2012; Lack of the detection of XMRV or polytropic MLV-related sequences in blood cells from HIV-1-infected patients in Spain. J Acquir Immune Defic Syndr59:101–104[PubMed][CrossRef]
    [Google Scholar]
  50. Maggi F., Focosi D., Lanini L., Sbranti S., Mazzetti P., Macera L., Davini S., De Donno M., Mariotti M. L.. other authors 2012; Xenotropic murine leukaemia virus-related virus is not found in peripheral blood cells from treatment-naive human immunodeficiency virus-positive patients. Clin Microbiol Infect18:184–188[PubMed][CrossRef]
    [Google Scholar]
  51. Maric R., Pedersen F. S., Kjeldbjerg A., Moeller-Larsen A., Bahrami S., Brudek T., Petersen T., Christensen T.. 2010; Absence of xenotropic murine leukaemia virus-related virus in Danish patients with multiple sclerosis. J Clin Virol49:227–228 [CrossRef][PubMed]
    [Google Scholar]
  52. Martinez-Fierro M. L., Leach R. J., Gomez-Guerra L. S., Garza-Guajardo R., Johnson-Pais T., Beuten J., Morales-Rodriguez I. B., Hernandez-Ordoñez M. A., Calderon-Cardenas G.. other authors 2010; Identification of viral infections in the prostate and evaluation of their association with cancer. BMC Cancer10:326 [CrossRef][PubMed]
    [Google Scholar]
  53. Metzger M. J., Holguin C. J., Mendoza R., Miller A. D.. 2010; The prostate cancer-associated human retrovirus XMRV lacks direct transforming activity but can induce low rates of transformation in cultured cells. J Virol84:1874–1880[CrossRef]
    [Google Scholar]
  54. Mi Z., Lu Y., Zhang S., An X., Wang X., Chen B., Wang Q., Tong Y.. 2012; Absence of xenotropic murine leukemia virus-related virus in blood donors in China. Transfusion52:326–331[PubMed][CrossRef]
    [Google Scholar]
  55. Mikovits J. A., Ruscetti F. W.. 2010; Response to comments on “Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome”. Science328:825[PubMed][CrossRef]
    [Google Scholar]
  56. Mikovits J. A., Lombardi V. C., Pfost M. A., Hagen K. S., Ruscetti F. W.. 2010; Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Virulence1:386–390 [CrossRef][PubMed]
    [Google Scholar]
  57. Oakes B., Tai A. K., Cingöz O., Henefield M. H., Levine S., Coffin J. M., Huber B. T.. 2010; Contamination of human DNA samples with mouse DNA can lead to false detection of XMRV-like sequences. Retrovirology7:109 [CrossRef][PubMed]
    [Google Scholar]
  58. Onlamoon N., Das Gupta J., Sharma P., Rogers K., Suppiah S., Rhea J., Molinaro R. J., Gaughan C., Dong B.. other authors 2011; Infection, viral dissemination, and antibody responses of rhesus macaques exposed to the human gammaretrovirus XMRV. J Virol85:4547–4557[CrossRef]
    [Google Scholar]
  59. Paprotka T., Venkatachari N. J., Chaipan C., Burdick R., Delviks-Frankenberry K. A., Hu W. S., Pathak V. K.. 2010; Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs. J Virol84:5719–5729 [CrossRef][PubMed]
    [Google Scholar]
  60. Paprotka T., Delviks-Frankenberry K. A., Cingöz O., Martinez A., Kung H. J., Tepper C. G., Hu W. S., Fivash M. J. Jr, Coffin J. M., Pathak V. K.. 2011; Recombinant origin of the retrovirus XMRV. Science333:97–101 [CrossRef][PubMed]
    [Google Scholar]
  61. Robinson M. J., Erlwein O. W., Kaye S., Weber J., Cingoz O., Patel A., Walker M. M., Kim W. J., Uiprasertkul M.. other authors 2010; Mouse DNA contamination in human tissue tested for XMRV. Retrovirology7:108 [CrossRef][PubMed]
    [Google Scholar]
  62. Rodriguez J. J., Goff S. P.. 2010; Xenotropic murine leukemia virus-related virus establishes an efficient spreading infection and exhibits enhanced transcriptional activity in prostate carcinoma cells. J Virol84:2556–2562 [CrossRef][PubMed]
    [Google Scholar]
  63. Ruscetti S. K.. 1999; Deregulation of erythropoiesis by the Friend spleen focus-forming virus. Int J Biochem Cell Biol31:1089–1109 [CrossRef][PubMed]
    [Google Scholar]
  64. Sakuma R., Sakuma T., Ohmine S., Silverman R. H., Ikeda Y.. 2010; Xenotropic murine leukemia virus-related virus is susceptible to AZT. Virology397:1–6 [CrossRef][PubMed]
    [Google Scholar]
  65. Sakuma T., Tonne J. M., Squillace K. A., Ohmine S., Thatava T., Peng K. W., Barry M. A., Ikeda Y.. 2011; Early events in retrovirus XMRV infection of the wild-derived mouse Mus pahari. . J Virol85:1205–1213[CrossRef]
    [Google Scholar]
  66. Sato E., Furuta R. A., Miyazawa T.. 2010; An endogenous murine leukemia viral genome contaminant in a commercial RT-PCR kit is amplified using standard primers for XMRV. Retrovirology7:110 [CrossRef][PubMed]
    [Google Scholar]
  67. Satterfield B. C., Garcia R. A., Gurrieri F., Schwartz C. E.. 2010; PCR and serology find no association between xenotropic murine leukemia virus-related virus (XMRV) and autism. Mol Autism1:14 [CrossRef][PubMed]
    [Google Scholar]
  68. Schlaberg R., Choe D. J., Brown K. R., Thaker H. M., Singh I. R.. 2009; XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proc Natl Acad Sci U S A106:16351–16356 [CrossRef][PubMed]
    [Google Scholar]
  69. Schmitt M., Höfler D., Koleganova N., Pawlita M.. 2011; Human polyomaviruses and other human viruses in neuroendocrine tumors. Cancer Epidemiol Biomarkers Prev20:1558–1561 [CrossRef][PubMed]
    [Google Scholar]
  70. Sfanos K. S., Aloia A. L., Hicks J. L., Esopi D. M., Steranka J. P., Shao W., Sanchez-Martinez S., Yegnasubramanian S., Burns K. H.. other authors 2011; Identification of replication competent murine gammaretroviruses in commonly used prostate cancer cell lines. PLoS One6:e20874 [CrossRef][PubMed]
    [Google Scholar]
  71. Shin C. H., Bateman L., Schlaberg R., Bunker A. M., Leonard C. J., Hughen R. W., Light A. R., Light K. C., Singh I. R.. 2011; Absence of XMRV retrovirus and other murine leukemia virus-related viruses in patients with chronic fatigue syndrome. J Virol85:7195–7202 [CrossRef][PubMed]
    [Google Scholar]
  72. Silverman R. H.. 2007; A scientific journey through the 2-5A/RNase L system. Cytokine Growth Factor Rev18:381–388 [CrossRef][PubMed]
    [Google Scholar]
  73. Silverman R. H., Das Gupta J., Lombardi V. C., Ruscetti F. W., Pfost M. A., Hagen K. S., Peterson D. L., Ruscetti S. K., Bagni R. K.. other authors 2011; Partial retraction. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science334:176 [CrossRef][PubMed]
    [Google Scholar]
  74. Simmons G., Glynn S. A., Komaroff A. L., Mikovits J. A., Tobler L. H., Hackett J. Jr, Tang N., Switzer W. M., Heneine W.. other authors 2011; Failure to confirm XMRV/MLVs in the blood of patients with chronic fatigue syndrome: a multi-laboratory study. Science334:814–817 [CrossRef][PubMed]
    [Google Scholar]
  75. Singh I. R.. 2010; Detecting retroviral sequences in chronic fatigue syndrome. Viruses2:2404–2408 [CrossRef][PubMed]
    [Google Scholar]
  76. Singh I. R., Gorzynski J. E., Drobysheva D., Bassit L., Schinazi R. F.. 2010; Raltegravir is a potent inhibitor of XMRV, a virus implicated in prostate cancer and chronic fatigue syndrome. PLoS One5:e9948 [CrossRef][PubMed]
    [Google Scholar]
  77. Smith R. A., Gottlieb G. S., Miller A. D.. 2010; Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors. Retrovirology7:70 [CrossRef][PubMed]
    [Google Scholar]
  78. Stieler K., Fischer N.. 2010; Apobec 3G efficiently reduces infectivity of the human exogenous gammaretrovirus XMRV. PLoS One5:e11738 [CrossRef][PubMed]
    [Google Scholar]
  79. Stieler K., Schulz C., Lavanya M., Aepfelbacher M., Stocking C., Fischer N.. 2010; Host range and cellular tropism of the human exogenous gammaretrovirus XMRV. Virology399:23–30 [CrossRef][PubMed]
    [Google Scholar]
  80. Stocking C., Kozak C. A.. 2008; Murine endogenous retroviruses. Cell Mol Life Sci65:3383–3398 [CrossRef][PubMed]
    [Google Scholar]
  81. Stoye J. P., Coffin J. M.. 1987; The four classes of endogenous murine leukemia virus: structural relationships and potential for recombination. J Virol61:2659–2669[PubMed]
    [Google Scholar]
  82. Sudlow C., Macleod M., Al-Shahi Salman R., Stone J.. 2010; Comment on “Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome”. Science328:825 [CrossRef][PubMed]
    [Google Scholar]
  83. Switzer W. M., Jia H., Hohn O., Zheng H., Tang S., Shankar A., Bannert N., Simmons G., Hendry R. M.. other authors 2010; Absence of evidence of xenotropic murine leukemia virus-related virus infection in persons with chronic fatigue syndrome and healthy controls in the United States. Retrovirology7:57 [CrossRef][PubMed]
    [Google Scholar]
  84. Tailor C. S., Nouri A., Lee C. G., Kozak C., Kabat D.. 1999; Cloning and characterization of a cell surface receptor for xenotropic and polytropic murine leukemia viruses. Proc Natl Acad Sci U S A96:927–932 [CrossRef][PubMed]
    [Google Scholar]
  85. Tang S., Zhao J., Haleyur Giri Setty M. K., Devadas K., Gaddam D., Viswanath R., Wood O., Zhang P., Hewlett I. K.. 2011a; Absence of detectable XMRV and other MLV-related viruses in healthy blood donors in the United States. PLoS One6:e27391 [CrossRef][PubMed]
    [Google Scholar]
  86. Tang S., Zhao J., Viswanath R., Nyambi P. N., Redd A. D., Dastyar A., Spacek L. A., Quinn T. C., Wang X.. other authors 2011b; Absence of detectable xenotropic murine leukemia virus-related virus in plasma or peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected blood donors or individuals in Africa. Transfusion51:463–468 [CrossRef][PubMed]
    [Google Scholar]
  87. Tuke P. W., Tettmar K. I., Tamuri A., Stoye J. P., Tedder R. S.. 2011; PCR master mixes harbour murine DNA sequences. Caveat emptor!. PLoS One6:e19953 [CrossRef][PubMed]
    [Google Scholar]
  88. Urisman A., Molinaro R. J., Fischer N., Plummer S. J., Casey G., Klein E. A., Malathi K., Magi-Galluzzi C., Tubbs R. R.. other authors 2006; Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog2:e25 [CrossRef][PubMed]
    [Google Scholar]
  89. van der Meer J. W., Netea M. G., Galama J. M., van Kuppeveld F. J.. 2010; Comment on “Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome”. Science328:825 [CrossRef][PubMed]
    [Google Scholar]
  90. van Kuppeveld F. J., de Jong A. S., Lanke K. H., Verhaegh G. W., Melchers W. J., Swanink C. M., Bleijenberg G., Netea M. G., Galama J. M., van der Meer J. W.. 2010; Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort. BMJ340:c1018 [CrossRef][PubMed]
    [Google Scholar]
  91. Voisset C., Weiss R. A., Griffiths D. J.. 2008; Human RNA “rumor” viruses: the search for novel human retroviruses in chronic disease. Microbiol Mol Biol Rev72:157–196 [CrossRef][PubMed]
    [Google Scholar]
  92. Waterston R. H., Lindblad-Toh K., Birney E., Rogers J., Abril J. F., Agarwal P., Agarwala R., Ainscough R., Alexandersson M.. other authors 2002; Initial sequencing and comparative analysis of the mouse genome. Nature420:520–562 [CrossRef][PubMed]
    [Google Scholar]
  93. Waugh E. M., Jarrett R. F., Shield L., Montgomery D., Dean R. T., Mitchell A., Greaves M. F., Gallagher A.. 2011; The retrovirus XMRV is not directly involved in the pathogenesis of common types of lymphoid malignancy. Cancer Epidemiol Biomarkers Prev20:2232–2236 [CrossRef][PubMed]
    [Google Scholar]
  94. Weiss R. A.. 2010; A cautionary tale of virus and disease. BMC Biol8:124 [CrossRef][PubMed]
    [Google Scholar]
  95. Wolff D., Gerritzen A.. 2011; Presence of murine leukemia virus (MLV)-related virus gene sequences in a commercial RT-PCR reagent. Clin Lab57:631–634[PubMed]
    [Google Scholar]
  96. Yang Y. L., Guo L., Xu S., Holland C. A., Kitamura T., Hunter K., Cunningham J. M.. 1999; Receptors for polytropic and xenotropic mouse leukaemia viruses encoded by a single gene at Rmc1. Nat Genet21:216–219 [CrossRef][PubMed]
    [Google Scholar]
  97. Yang J., Battacharya P., Singhal R., Kandel E. S.. 2011; Xenotropic murine leukemia virus-related virus (XMRV) in prostate cancer cells likely represents a laboratory artifact. Oncotarget2:358–362[PubMed]
    [Google Scholar]
  98. Zhou A., Hassel B. A., Silverman R. H.. 1993; Expression cloning of 2-5A-dependent RNAase: a uniquely regulated mediator of interferon action. Cell72:753–765 [CrossRef][PubMed]
    [Google Scholar]
  99. Zhou A., Paranjape J., Brown T. L., Nie H., Naik S., Dong B., Chang A., Trapp B., Fairchild R.. other authors 1997; Interferon action and apoptosis are defective in mice devoid of 2′,5′-oligoadenylate-dependent RNase L.. EMBO J16:6355–6363 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.041038-0
Loading
/content/journal/jgv/10.1099/vir.0.041038-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error